Literature DB >> 1724553

Effect of guanidinoethanesulfonic acid on brain monoamines in the mouse.

Y Watanabe1, S Watanabe, I Yokoi, A Mori.   

Abstract

Guanidinoethanesulfonic acid (GES) is known to induce convulsive seizures when administered intracisternally to rabbits and cats. The effects of GES on behavior, electroencephalographic recording and brain monoamine levels were examined in mice. When GES (900 nmol) was intraventricularly injected into mice, focal clonic movements of the face, vibrissae and ears together with twitching of the limbs were observed 0.5-1 min after the injection. Hypersensitivity was observed up to 7 min after the injection, after which the mice behaved normally. GES also induced sporadic spike discharges on electrocorticogram. The levels of 5-hydroxytryptamine (5-HT) of the GES-injected mice were lower than those of the saline-injected mice in the hippocampus, diencephalon, pons-medulla oblongata and cerebellum 5 min after the injection. No changes in the norepinephrine or dopamine levels were found after the GES injection. The level of 5-hydroxyindoleacetic acid increased in the striatum and cerebellum 5 min after the GES injection. These results suggest that GES-induced convulsive activities enhance the serotonergic neuroactivity in order to suppress the convulsions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724553     DOI: 10.1007/bf00966594

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  Guanidino compounds in the sera of uremic patients and in the sera and brain of experimental uremic rabbits.

Authors:  M Matsumoto; H Kishikawa; A Mori
Journal:  Biochem Med       Date:  1976-08

2.  The relative significance of norepinephrine, dopamine and 5-hydroxytryptamine in electroshock seizure in the rat.

Authors:  P C Jobe; R E Stull; P F Geiger
Journal:  Neuropharmacology       Date:  1974-11       Impact factor: 5.250

3.  Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.

Authors:  A J Azzaro; G R Wenger; C R Craig; R E Stitzel
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

4.  Studies on brain guanidino compounds by automatic liquid chromatography.

Authors:  A Mori; M Hosotani; T L Choong
Journal:  Biochem Med       Date:  1974-05

5.  The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate.

Authors:  R J Huxtable; H E Laird; S E Lippincott
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

6.  Serotonergic mechanisms in amygdaloid-kindled seizures in the rat.

Authors:  K E Munkenbeck; W S Schwark
Journal:  Exp Neurol       Date:  1982-05       Impact factor: 5.330

7.  Taurine: sodium-dependent, high-affinity transport into rat brain synaptosomes.

Authors:  R E Hruska; A Padjen; R Bressler; H I Yamamura
Journal:  Mol Pharmacol       Date:  1978-01       Impact factor: 4.436

8.  Application of a newly developed electrochemical detector for liquid chromatography to the assay of brain catecholamines.

Authors:  Y Maruyama; N Iida; M Kusaka; A Horikawa; J Mori; K Munekiyo
Journal:  Prog Neuropsychopharmacol       Date:  1978

9.  Genetics of audiogenic seizures. I. Relation to brain serotonin and norepinephrine in mice.

Authors:  K Schlesinger; W Boggan; D X Freedman
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037

10.  Behavioural changes induced in conscious mice by intracerebroventricular injection of catecholamines, acetylcholine and 5-hydroxytryptamine.

Authors:  Z S Herman
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

View more
  1 in total

1.  Effects of GABAmimetics on electrocorticographic spike discharges induced by guanidinoethanesulfonic acid (amidino-taurine) in the rat.

Authors:  I Yokoi; H Kabuto; A Mori
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.